Antioxidant properties of butylated phenol with oxadiazole and hydrazone moiety atorthoposition supported by DFT study

Raied M. Shakira, Muhammad Kumayl Abd Wahab, Nurdiana Nordin and Azhar Ariffin

RSC Adv., 2022, 12, 17085
DOI: 10.1039/D2RA02140D

The latest strategies in the fight against the COVID-19 pandemic: the role of metal and metal oxide nanoparticles

Shadpour Mallakpour, Elham Azadi and Chaudhery Mustansar Hussain

New J. Chem., 2021, 45, 6167
DOI: 10.1039/D1NJ00047K

Proposing high-affinity inhibitors fromGlycyrrhiza glabraL. against SARS-CoV-2 infection: virtual screening and computational analysis

Mina Maddah, Roodabeh Bahramsoltani, Nafiseh Hoseini Yekta, Roja Rahimi, Rasoul Aliabadi and Mahdi Pourfath

New J. Chem., 2021, 45, 15977
DOI: 10.1039/D1NJ02031E

A critical overview of computational approaches employed for COVID-19 drug discovery

Eugene N. Muratov, Rommie Amaro, Carolina H. Andrade, Nathan Brown, Sean Ekins, Denis Fourches, Olexandr Isayev, Dima Kozakov, José L. Medina-Franco, Kenneth M. Merz, Tudor I. Oprea, Vladimir Poroikov, Gisbert Schneider, Matthew H. Todd, Alexandre Varnek, David A. Winkler, Alexey V. Zakharov, Artem Cherkasov and Alexander Tropsha

Chem. Soc. Rev., 2021, 50, 9121
DOI: 10.1039/D0CS01065K

Synthesis of N'-(Substituted)-2-(4-(3-nitroimidazo[1,2-b]pyridazin-6-yl)piperazin-1-yl)acetohydrazides and their 1,3,4-Oxadiazole Derivatives: Characterization, Antimicrobial Activity and Molecular Docking Studies

B. Subba Rao, P. Sanjeeva, P. Karuna Raman, V. Satyanarayana Swamy, V. Kamala Prasad and P. Venkata Ramana

ajomc, 2022, 7, 187
DOI: 10.14233/ajomc.2022.AJOMC-P384

Efficacy and safety evaluation of Azvudine in the prospective treatment of COVID-19 based on four phase III clinical trials

Ke-Wei Zhu

Front. Pharmacol., 2023, 14
DOI: 10.3389/fphar.2023.1228548

In Silico Study in MPO and Molecular Docking of the Synthetic Drynaran Analogues Against the Chronic Tinnitus: Modulation of the M1 Muscarinic Acetylcholine Receptor

Matheus Nunes da Rocha, Aluísio Marques da Fonseca, Adriana Nogueira Machado Dantas, Hélcio Silva dos Santos, Emmanuel Silva Marinho and Gabrielle Silva Marinho

Mol Biotechnol, 2024, 66, 254
DOI: 10.1007/s12033-023-00748-5

Probing conserved catalytic domains in RNA polymerases of severe acute respiratory syndrome coronavirus, human metapneumovirus and respiratory syncytial virus for computational insights

Romita Guchhait, Soumya Basu, Rayapadi G. Swetha, Hithesh Kumar, Deepak Kumar Jha, Likun Panda, Sudha Ramaiah and Anand Anbarasu

Results in Chemistry, 2026, 21, 103075
DOI: 10.1016/j.rechem.2026.103075

Synthesis and Biological Evaluation of Honokiol Derivatives Bearing 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3H)-ones as Potential Viral Entry Inhibitors against SARS-CoV-2

Yong Guo, Jie-Ru Meng, Jia-Zheng Liu, Ting Xu, Zhi-Yuan Zheng, Zhi-Hong Jiang and Li-Ping Bai

Pharmaceuticals, 2021, 14, 885
DOI: 10.3390/ph14090885

Dual inhibition of inflammatory mediators and Coronaviridae main proteases by 2,5-disubstituted 1,3,4-oxadiazoles: a computational study

Armin Zarei, Aram Rezaei and Ali Ramazani

Journal of Molecular Liquids, 2025, 435, 128088
DOI: 10.1016/j.molliq.2025.128088

Association between dietary antioxidant quality score and severity of coronavirus infection: a case–control study

Mobina Aghajani, Alexei Wong, Mehdi Azimi and Shadmehr Mirdar Harijani

Front. Nutr., 2023, 10
DOI: 10.3389/fnut.2023.1174113

The Expression of Hypoxia-inducible Factor-1 Alpha (HIF-1α) as a Potential Target for Hypoxic Therapy in COVID-19 Cases

Endah Wulandari, Rr Ayu Fitri Hapsari, Francisca Tjakradidjaja, Alfiah and Auliyani Andam Suri

COVID, 2025, 6
DOI: 10.2174/0126667975278373240516152940

Exploration of the anti-SARS-CoV-2 potential and expected mechanisms of small molecules from Antrodia cinnamomea by BT&D2 drug-targeting analysis

Arshdeep Singh, Shu-Han Xu, You-Da Tsai, Zih-Syuan Yang, Hung-Jen Tang, Yi-Ju Tsai, Hui-Yu Tsai, Che-Wei Yuan, Chi-Chung Chen, Arunee Thitithanyanont, Sheng-Fan Wang and Hsien-Tai Chiu

Bioorganic Chemistry, 2025, 163, 108646
DOI: 10.1016/j.bioorg.2025.108646

Potential inhibitory properties of structurally modified quercetin/isohamnetin glucosides against SARS-CoV-2 Mpro; molecular docking and dynamics simulation strategies

Peter Ifeoluwa Adegbola, Olumide Samuel Fadahunsi, Oluwasayo Esther Ogunjinmi, Aanuoluwa Eunice Adegbola, Fiyinfoluwa Demilade Ojeniyi, Adetayo Adesanya, Emmanuel Olagoke, Ayobami Damilare Adisa, Adeola Folasade Ehigie, Adewale Adetutu and Banjo Semire

Informatics in Medicine Unlocked, 2023, 37, 101167
DOI: 10.1016/j.imu.2023.101167

A Series of Adenosine Analogs as the First Efficacious Anti‐SARS‐CoV‐2 Drugs against the B.1.1.529.4 Lineage: A Preclinical Repurposing Research Study

Amgad M. Rabie and Mohnad Abdalla

ChemistrySelect, 2022, 7
DOI: 10.1002/slct.202201912

Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2

Mohamed S. Bekheit, Siva S. Panda and Adel S. Girgis

European Journal of Medicinal Chemistry, 2023, 252, 115292
DOI: 10.1016/j.ejmech.2023.115292

Could eggshell membrane be an adjuvant for recombinant Hepatitis B vaccine?: A preliminary investigation

Parker Elijah Joshua, Charity Chinyere Ilo, Uzochukwu Gospel Ukachukwu, Damian Chukwu Odimegwu, Rita Onyekachukwu Asomadu and Timothy Prince Chidike Ezeorba

Futur J Pharm Sci, 2023, 9
DOI: 10.1186/s43094-023-00481-5

Design, synthesis, and in-vitro/in-vivo pharmacodynamic studies of novel aza-fused heterocyclic compounds against herpes simplex virus type 1

Wenhua Xue, Ying Qu, Shouye Ma, Ziyan Li, Su Lyu, Xiaoqiong Diao, Kai Sun, Zhenya Wang and Ranran Sun

Bioorganic Chemistry, 2025, 162, 108589
DOI: 10.1016/j.bioorg.2025.108589

Antrodia cinnamomea May Interfere with the Interaction Between ACE2 and SARS-CoV-2 Spike Protein in vitro and Reduces Lung Inflammation in a Hamster Model of COVID-19

Lan-Hui Li, Hsiao-Wen Chiu, Wei-Ting Wong, Ko-Chieh Huang, Tzu-Wen Lin, Shui-Tein Chen and Kuo-Feng Hua

JIR, 2023, Volume 16, 4867
DOI: 10.2147/JIR.S431222

Acid-catalyzed Cyclization of α-Ketodithioesters and Acyl Hydrazides: A Divergent and Regioselective Synthesis of 2,5-Disubstituted-1,3,4-thiadiazoles and 1,3,4-Oxadiazoles

Kalleshappa Sharath, Chikkappaiahnayaka Santhosh, Kalleshappa Sheela, R. Nandini, Manoj V. Mane, Krishna Ravi Singh and Maralinganadoddi P. Sadashiva

Synthesis, 2026, 58, 661
DOI: 10.1055/a-2743-3444

Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study

Amgad M. Rabie and Wafa A. Eltayb

Mol Biotechnol, 2024, 66, 592
DOI: 10.1007/s12033-022-00551-8

Evaluation of a series of nucleoside analogs as effective anticoronaviral-2 drugs against the Omicron-B.1.1.529/BA.2 subvariant: A repurposing research study

Amgad M. Rabie and Mohnad Abdalla

Med Chem Res, 2023, 32, 326
DOI: 10.1007/s00044-022-02970-3

Are Tetrapleura tetraptera Phytochemicals Druggable Against SARS‐CoV‐2 Papain‐Like Protein? A Computational Approach

Frank Eric Tatsing Foka and Hazel Tumelo Mufhandu

New Zealand Journal of Botany, 2026, 64
DOI: 10.1002/nzb2.70039

Study of Oxadiazole derivatives as precursor for multi-functional inhibitor to SARS-CoV-2: A detailed virtual screening analysis

Vikash Kumar and Sumit Kumar

Mong. J. Chem., 2024, 25, 1
DOI: 10.5564/mjc.v25i51.2909

Synthesis and Biological Evaluation of Cholic Acid Tagged Piperazine Derivatives

Dima W. Alshawabkeh, Anas J. Rasras, Saqr Abushattal, Mohammad S. Al Zubi, Mohamad M. Shakdofa, Eyad A. Younes and Raed A. Al-Qawasmeh

COC, 2024, 28, 65
DOI: 10.2174/0113852728281288240109113216

Comparative study of the interaction of ivermectin with proteins of interest associated with SARS-CoV-2: A computational and biophysical approach

Lenin González-Paz, María Laura Hurtado-León, Carla Lossada, Francelys V. Fernández-Materán, Joan Vera-Villalobos, Marcos Loroño, J.L. Paz, Laura Jeffreys and Ysaias J. Alvarado

Biophysical Chemistry, 2021, 278, 106677
DOI: 10.1016/j.bpc.2021.106677

UNVEILING THE POTENTIAL OF OXADIAZOLE TRIAZINE NUCLEOSIDE DERIVATIVE AS AN INHIBITOR OF SARS COV-2: A COMPUTATIONAL BREAKTHROUGH

Madhu Sudan, Sarika Arora and Danveer Singh Yadav

ShodhKosh J. Vis. Per. Arts, 2024, 5
DOI: 10.29121/shodhkosh.v5.i6.2024.2761

Predictive Assessment of the Antiviral Properties of Imperata cylindrica against SARS‐CoV‐2

Frank Eric Tatsing Foka, Hazel Tumelo Mufhandu and Carla Zannella

Advances in Virology, 2024, 2024
DOI: 10.1155/2024/8598708

A Review of Computational Approaches Targeting SARS-CoV-2 Main Protease to the Discovery of New Potential Antiviral Compounds

Juan A. Castillo-Garit, Yudith Cañizares-Carmenate, Hai Pham-The, Virginia Pérez-Doñate, Francisco Torrens and Facundo Pérez-Giménez

CTMC, 2023, 23, 3
DOI: 10.2174/2667387816666220426133555

WITHDRAWN: Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage)

Amgad M. Rabie and Wafa A. Eltayb

Advances in Redox Research, 2023, 100064
DOI: 10.1016/j.arres.2023.100064

GC-MS profiling of Bauhinia variegata major phytoconstituents with computational identification of potential lead inhibitors of SARS-CoV-2 Mpro

Pallavi More-Adate, Kiran Bharat Lokhande, K. Venkateswara Swamy, Shuchi Nagar and Akshay Baheti

Computers in Biology and Medicine, 2022, 147, 105679
DOI: 10.1016/j.compbiomed.2022.105679

Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial

Maria Boesing, Kristin Abig, Michael Brändle, Martin Brutsche, Emanuel Burri, Björn C. Frye, Stéphanie Giezendanner, Jan C. Grutters, Philippe Haas, Justian Heisler, Fabienne Jaun, Anne B. Leuppi-Taegtmeyer, Giorgia Lüthi-Corridori, Joachim Müller-Quernheim, Reto Nüesch, Wolfgang Pohl, Frank Rassouli and Jörg D. Leuppi

Trials, 2022, 23
DOI: 10.1186/s13063-022-06723-w

Discovery of Taroxaz-104: The first potent antidote of SARS-CoV-2 VOC-202012/01 strain

Amgad M. Rabie

Journal of Molecular Structure, 2021, 1246, 131106
DOI: 10.1016/j.molstruc.2021.131106

Clinical effectiveness of oral antivirals for non-hospitalized adult COVID-19 patients aged 18–60 years

Wan-Hsuan Hsu, Bo-Wen Shiau, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang and Chih-Cheng Lai

Expert Review of Anti-infective Therapy, 2024, 22, 1229
DOI: 10.1080/14787210.2024.2419579

Efficacious Preclinical Repurposing of the Nucleoside Analogue Didanosine against COVID-19 Polymerase and Exonuclease

Amgad M. Rabie

ACS Omega, 2022, 7, 21385
DOI: 10.1021/acsomega.1c07095

The effectiveness of novel oral antiviral treatment for non-hospitalized high-risk patients with COVID-19 during predominance of omicron XBB subvariants

Chi-Kuei Hsu, Wan-Hsuan Hsu, Bo-Wen Shiau, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang and Chih-Cheng Lai

Expert Review of Anti-infective Therapy, 2024, 22, 785
DOI: 10.1080/14787210.2024.2339398

Effectiveness of azvudine against severe outcomes among hospitalized COVID-19 patients in Xinjiang, China: a single-center, retrospective, matched cohort study

Abiden Kapar, Songsong Xie, Zihao Guo, Yan Nan, Yaling Du, Xi Yin, Tao Gong, Xiu Gu, Yang Zhou, Wenli Lu, Aimin Yang, Zhaohui Luo, Jianghong Dai, Kailu Wang, Shi Zhao and Kai Wang

Expert Review of Anti-infective Therapy, 2024, 22, 569
DOI: 10.1080/14787210.2024.2362900

A Novel Pancreatic Cancer Hypoxia Status Related Gene Signature for Prognosis and Therapeutic Responses

Min Ren, Jianing Zhang, Rongrong Zong and Huiru Sun

Mol Biotechnol, 2024, 66, 1684
DOI: 10.1007/s12033-023-00807-x

Targeting matrix metalloproteinase-9 (MMP9) in prostate cancer: a computational study on natural product-derived novel potential inhibitors

Vipendra Kumar Singh, Naina Rajak, Prashant Kumar Gupta, Arun Kumar Mahapatra, Ankit Kumar Singh, Rajanish Giri and Neha Garg

Futur J Pharm Sci, 2025, 11
DOI: 10.1186/s43094-025-00838-y

Cholyl 1,3,4-oxadiazole hybrid compounds: design, synthesis and antimicrobial assessment

Anas J Rasras, Mohamed El-Naggar, Nesreen A Safwat and Raed A Al-Qawasmeh

Beilstein J. Org. Chem., 2022, 18, 631
DOI: 10.3762/bjoc.18.63

Structural basis of SARS-CoV-2 polymerase inhibition by nonnucleoside inhibitor HeE1-2Tyr

Florian Kabinger, Valerie Doze, Jana Schmitzová, Michael Lidschreiber, Christian Dienemann and Patrick Cramer

Proc. Natl. Acad. Sci. U.S.A., 2025, 122
DOI: 10.1073/pnas.2419854122

RNA-targeted small-molecule drug discoveries: a machine-learning perspective

Huan Xiao, Xin Yang, Yihao Zhang, Zongkang Zhang, Ge Zhang and Bao-Ting Zhang

RNA Biology, 2023, 20, 384
DOI: 10.1080/15476286.2023.2223498

The potential protective effect of melatonin and N-acetylcysteine alone and in combination on opioid-induced testicular dysfunction and degeneration in rat

Niloofar Mohammadi, Sadegh Shirian, Ali Gorji, Mohsen Roshanpajouh, Ebrahim Ahmadi, Hassan Nazari and Reza Arezoomandan

Reproductive Toxicology, 2023, 120, 108453
DOI: 10.1016/j.reprotox.2023.108453

Identification of a glycolysis-related miRNA Signature for Predicting Breast cancer Survival

Xuejing Shi, Baoqiang Xiao and Rui Feng

Mol Biotechnol, 2024, 66, 1988
DOI: 10.1007/s12033-023-00837-5

RETRACTED: Promising Experimental Anti-SARS-CoV-2 Agent “SLL-0197800”: The Prospective Universal Inhibitory Properties against the Coming Versions of the Coronavirus

Amgad M. Rabie, Marwa A. Abdel-Dayem and Mohnad Abdalla

ACS Omega, 2023, 8, 35538
DOI: 10.1021/acsomega.2c08073

Only Biomedicines-Meals (BM) Act as the ‘Preventive-Immunity-Booster-Community-Vaccine (PIBCV)’ Against ‘Omicron’ Enriching Global-Public-Health Forestry-Agriculture-Environment-Biodiversity-Wildlife-Conservation-Medical-Research-Science-Technology-Communication-Applications (GPHFAEBWCMRSTCA)?

Subhas Chandra Datta and Ranjan Mukherjee

Arch Community Med Public Health, 2022, 8, 025
DOI: 10.17352/2455-5479.000170

RNA: The most attractive target in recent viral diseases

Amgad M. Rabie

Chem Biol Drug Des, 2024, 103
DOI: 10.1111/cbdd.14404

Potent Inhibitory Activities of the Adenosine Analogue Cordycepin on SARS-CoV-2 Replication

Amgad M. Rabie

ACS Omega, 2022, 7, 2960
DOI: 10.1021/acsomega.1c05998

Design, synthesis, and biological evaluation of novel double-winged galloyl derivatives as HIV-1 RNase H inhibitors

Lina Zhang, Fenju Wei, David Borrego, Fabao Zhao, Javier Martínez del Río, Estrella Frutos-Beltrán, Jiwei Zhang, Shujing Xu, Nerea López-Carrobles, Shenghua Gao, Dongwei Kang, Christophe Pannecouque, Erik De Clercq, Xinyong Liu, Luis Menéndez-Arias and Peng Zhan

European Journal of Medicinal Chemistry, 2022, 240, 114563
DOI: 10.1016/j.ejmech.2022.114563

Unveiling the chemistry of 1,3,4‐oxadiazoles and thiadiazols: A comprehensive review

Vivek K. Gour, Shaikh Yahya and Mohammad Shahar Yar

Archiv der Pharmazie, 2024, 357
DOI: 10.1002/ardp.202300328

Exploring the DNA-binding and anticancer potential of polypyridyl ruthenium(II) complexes

Dandan Zhang, Mengshan Li, A.F.M. Motiur Rahman, Zhongyang Liu and Yang Lu

Journal of Molecular Structure, 2025, 1321, 140044
DOI: 10.1016/j.molstruc.2024.140044

Main Chemotypes of SARS-CoV-2 Reproduction Inhibitors

V. A. Shiryaev and Yu. N. Klimochkin

Russ J Org Chem, 2021, 57, 730
DOI: 10.1134/S107042802105002X

Understanding the mutational frequency in SARS-CoV-2 proteome using structural features

Puneet Rawat, Divya Sharma, Medha Pandey, R. Prabakaran and M. Michael Gromiha

Computers in Biology and Medicine, 2022, 147, 105708
DOI: 10.1016/j.compbiomed.2022.105708

Retraction Note: CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy

Amgad M. Rabie

Mol Divers, 2023, 27, 1529
DOI: 10.1007/s11030-022-10521-6

Design, synthesis, and biological activity evaluation of dihydromyricetin derivatives against SARS-CoV-2-Omicron virus

Cong Wu, Qi Jiang, Hui Zhong, Xudong Zhou, Leping Liu, Tong Pan, Chao Liu, Wei Wang and Wenbing Sheng

Journal of Enzyme Inhibition and Medicinal Chemistry, 2024, 39
DOI: 10.1080/14756366.2024.2390909

Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles

Amgad M. Rabie

Chemico-Biological Interactions, 2021, 343, 109480
DOI: 10.1016/j.cbi.2021.109480

Synthesis and Biological Activity of Some New 1,3,4-Oxadiazoles Derived from Carboxylic Acids

I. A. A. Hamdan and J. H. Tomma

Russ J Org Chem, 2024, 60, 164
DOI: 10.1134/S1070428024010214

Synthesis, characterization, molecular docking, and anticancer activities of new 1,3,4-oxadiazole-5-fluorocytosine hybrid derivatives

Az-eddine El Mansouri, Saida Lachhab, Ali Oubella, Ahmad Mehdi, Johan Neyts, Dirk Jochmans, Winston Chiu, Laura Vangeel, Steven De Jonghe, Hamid Morjani, Mustapha Ait Ali, Mohamed Zahouily, Yogesh S. Sanghvi and Hassan B. Lazrek

Journal of Molecular Structure, 2023, 1272, 134135
DOI: 10.1016/j.molstruc.2022.134135

Computational screening of natural products to identify potential inhibitors for human neuropilin-1 (NRP1) receptor to abrogate the binding of SARS-CoV-2 and host cell

Alaa Karkashan and Roba Attar

Journal of Biomolecular Structure and Dynamics, 2023, 41, 9987
DOI: 10.1080/07391102.2022.2150685

1,3,4‐oxadiazole derivatives as potential antimicrobial agents

Deeksha Tiwari, Rakesh Narang, Kalvatala Sudhakar, Vikramjeet Singh, Sukhbir Lal and Manish Devgun

Chem Biol Drug Des, 2022, 100, 1086
DOI: 10.1111/cbdd.14100

LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells

Zhiwei Zhang, Yanli Yi, Zai Wang, Haoyun Zhang, Yanchun Zhao, Ruijing He, Yan Luo and Zhiqiang Cui

Mol Biotechnol, 2024, 66, 1409
DOI: 10.1007/s12033-023-00801-3

Scaffolds of biologically active heterocyclic compounds for discovery of potential drug against SARS-CoV-2

Archana R. Patil, Basappa C. Yallur, Geetika Pant, Eliza Ahmed, S.G. Prasanna Kumar, Sheetal R. Batakurki and Anjanapura V. Raghu

Results in Chemistry, 2025, 15, 102154
DOI: 10.1016/j.rechem.2025.102154

Interaction of the new inhibitor paxlovid (PF-07321332) and ivermectin with the monomer of the main protease SARS-CoV-2: A volumetric study based on molecular dynamics, elastic networks, classical thermodynamics and SPT

Ysaias José Alvarado, Yosmari Olivarez, Carla Lossada, Joan Vera-Villalobos, José Luis Paz, Eddy Vera, Marcos Loroño, Alejandro Vivas, Fernando Javier Torres, Laura N. Jeffreys, María Laura Hurtado-León and Lenin González-Paz

Computational Biology and Chemistry, 2022, 99, 107692
DOI: 10.1016/j.compbiolchem.2022.107692

Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant

Mohnad Abdalla and Amgad M. Rabie

Computational Biology and Chemistry, 2023, 104, 107768
DOI: 10.1016/j.compbiolchem.2022.107768

In-silico design of a new multi-epitope vaccine candidate against SARS-CoV-2

Abbas Alibakhshi, Armina Alagheband Bahrami, Elmira Mohammadi, Shahrzad Ahangarzadeh and Meysam Mobasheri

Acta Virol., 2024, 67
DOI: 10.3389/av.2023.12481

Impact of some antiviral drugs on health care utilization for patients with COVID-19: a systematic review and meta-analysis

Bincai Wei, Ruhao Zhang, Huatang Zeng, Liqun Wu, Rongxin He, Junyao Zheng, Hao Xue, Jinlin Liu, Fengchao Liang and Bin Zhu

Expert Review of Anti-infective Therapy, 2023, 21, 993
DOI: 10.1080/14787210.2023.2254491

New halogenated chalcones as potential anti-inflammatory agents: A comprehensive In-Silico, In-Vitro, and In-Vivo study with ADME profiling

Rabia Iqtadar, Asia Naz, Syed Adnan Ali Shah, Sana Ali and Sabahat Abdullah

Journal of Molecular Structure, 2025, 1326, 141055
DOI: 10.1016/j.molstruc.2024.141055

Natural flavonoid pectolinarin computationally targeted as a promising drug candidate against SARS-CoV-2

Mukta Rani, Amit Kumar Sharma, R.S. Chouhan, Souvik Sur, Rani Mansuri and Rajesh K. Singh

Current Research in Structural Biology, 2024, 7, 100120
DOI: 10.1016/j.crstbi.2023.100120

Teriflunomide: A possible effective drug for the comprehensive treatment of COVID-19

Amgad M. Rabie

Current Research in Pharmacology and Drug Discovery, 2021, 2, 100055
DOI: 10.1016/j.crphar.2021.100055

Application and Development of Targeted Fishing Technology in Natural Product Screening - A Simple Minireview

Yingying Su, Weiping Wang, Ying Wang, Chen Wang, Shuai Sun, Xianhong Zhu, Xiao Dai, Shiyu Li, Xun Gao and Kunming Qin

CPA, 2024, 20, 231
DOI: 10.2174/0115734129301241240429114323

Synthesis, Antimicrobial Activity and Molecular Docking of New N-Acylated Derivatives of 5-(3-Phenoxyphenyl)-1,3,4-oxadiazol-2-amine

Kadeer Md, R. K. Parangi, G. Prabhakar and R. Domala

Russ J Gen Chem, 2025, 95, 1417
DOI: 10.1134/S1070363225601346

Novel Investigational Anti-SARS-CoV-2 Agent Ensitrelvir “S-217622”: A Very Promising Potential Universal Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus Species

Wafa A. Eltayb, Mohnad Abdalla and Amgad M. Rabie

ACS Omega, 2023, 8, 5234
DOI: 10.1021/acsomega.2c03881

Neurometabolite, myo-inositol, induces conformational distortion with enhanced aggregation of Carbonic Anhydrase: Implications for altered metabolite levels in Alzheimer's disease

Ishfaq Ahmad Ahanger, Owais Hassan Wani, Yueshan Zhong, Syed Hussain Mir, Faez Iqbal Khan and Tanveer Ali Dar

Journal of Molecular Structure, 2025, 1325, 141054
DOI: 10.1016/j.molstruc.2024.141054

First-in-human clinical trial of high-dose sodium copper chlorophyllin: Pharmacology and efficacy as a dual immunomodulatory/antiviral agent

Raghavendra S. Patwardhan, Zaigham Abbas Rizvi, Vikram Gota, Rahul Checker, Babita Singh, Dharmendra K. Maurya, Debojyoti Pal, Neha Ramani, Binita K Kumar, Vaitashi Purohit, Basavaraj S. Mathapati, Jayati Mullick, Tapan K. Ghanty, Sudeep Gupta, Mahendra Joshi, Shivkumar Madki, Amit Awasthi, Santosh K. Sandur and Deepak Sharma

Phytomedicine, 2026, 150, 157689
DOI: 10.1016/j.phymed.2025.157689

Computational exploration of the dual role of the phytochemical fortunellin: Antiviral activities against SARS-CoV-2 and immunomodulatory abilities against the host

Shivangi Agrawal, Ekta Pathak, Rajeev Mishra, Vibha Mishra, Afifa Parveen, Sunil Kumar Mishra, Parameswarappa S. Byadgi, Sushil Kumar Dubey, Ashvanee Kumar Chaudhary, Vishwambhar Singh, Rameshwar Nath Chaurasia and Neelam Atri

Computers in Biology and Medicine, 2022, 149, 106049
DOI: 10.1016/j.compbiomed.2022.106049

Synthesis and crystal structure, Hirshfeld surface analysis, and DFT calculation of 2-((4-(1-benzyl-2-methyl-4-nitro-1H-imidazol-5-yl)piperazin-1-yl)methyl)-5-phenyl-1,3,4-oxadiazole

Anas J. Rasras, Rawhi H. Al-Far, Eyad A. Younes, Mohamad M. Shakdofa and Nafisah M. Al-Rifai

Journal of Molecular Structure, 2023, 1280, 135069
DOI: 10.1016/j.molstruc.2023.135069

Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study

Xue Zhong, Chao Wang, Lin Huang, Yue Zhao, Tianyi Li, Jing He and Xiaohong Zhang

Front. Pharmacol., 2023, 14
DOI: 10.3389/fphar.2023.1288402

Failed clinical trials on COVID-19 acute respiratory distress syndrome in hospitalized patients: common oversights and streamlining the development of clinically effective therapeutics

Denise Battaglini, Fernanda Cruz, Chiara Robba, Paolo Pelosi and Patricia R.M. Rocco

Expert Opinion on Investigational Drugs, 2022, 31, 995
DOI: 10.1080/13543784.2022.2120801

Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes)

Evgenii Gusev, Alexey Sarapultsev, Desheng Hu and Valeriy Chereshnev

IJMS, 2021, 22, 7582
DOI: 10.3390/ijms22147582

Unveiling Potential Targeted Therapeutic Opportunities for Co-Overexpressed Targeting Protein for Xklp2 and Aurora-A Kinase in Lung Adenocarcinoma

Arnab Mukherjee, Preeti Harigovind Yadav and K. S. Mukunthan

Mol Biotechnol, 2024, 66, 2792
DOI: 10.1007/s12033-023-00879-9

Forodesine and Riboprine Exhibit Strong Anti-SARS-CoV-2 Repurposing Potential: In Silico and In Vitro Studies

Amgad M. Rabie and Mohnad Abdalla

ACS Bio Med Chem Au, 2022, 2, 565
DOI: 10.1021/acsbiomedchemau.2c00039

Protective effect of symmetrical N‐heterocyclic 1,3,4‐oxadiazole and 1,3,4‐thiadiazole derivatives against Pepino mosaic virus of tomato

Kasmi Imane, Esserti Siham, Makroum Kacem, Belfaizea Malika, Koussa Tayeb, Rifai Lalla Aicha, Faize Lydia, Venisse Jean Stéphane, Bentiss Fouad, Smaili Amal and Faize Mohamed

Journal of Phytopathology, 2022, 170, 557
DOI: 10.1111/jph.13105

Synthesis, In Silico Analysis, and Larvicidal Activity of New Bis-oxadiazole Derivatives

Rakesh Balije, Prasad A, Perugu Shyam and Amar nath Velidandi

Russ J Org Chem, 2023, 59, 158
DOI: 10.1134/S1070428023010177

Structure-Based Design and In-Silico Evaluation of Computationally Proposed Curcumin Derivatives as Potential Inhibitors of the Coronaviral PLpro Enzymes

Hakan Alici

Pharmaceuticals, 2025, 18, 798
DOI: 10.3390/ph18060798

Discovery of druggable potent inhibitors of serine proteases and farnesoid X receptor by ligand-based virtual screening to obstruct SARS-CoV-2

Sumera Zaib, Nehal Rana, Hafiz Saqib Ali, Nadia Hussain, Areeba, Hanan A. Ogaly, Fatimah A.M. Al-Zahrani and Imtiaz Khan

International Journal of Biological Macromolecules, 2023, 253, 127379
DOI: 10.1016/j.ijbiomac.2023.127379

Computational identification of differentially-expressed genes as suggested novel COVID-19 biomarkers: A bioinformatics analysis of expression profiles

Valentina Di Salvatore, Elena Crispino, Avisa Maleki, Giulia Nicotra, Giulia Russo and Francesco Pappalardo

Computational and Structural Biotechnology Journal, 2023, 21, 3339
DOI: 10.1016/j.csbj.2023.06.007

Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive pulmonary diseases

Bo-Wen Shiau, Wan-Hsuan Hsu, Ya-Wen Tsai, Jheng-Yan Wu, Ting-Hui Liu, Po-Yu Huang, Min-Hsiang Chuang, Chih-Cheng Lai and Lih-Wen Jang

Expert Review of Anti-infective Therapy, 2024, 22, 977
DOI: 10.1080/14787210.2024.2351571